ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

IHC Inspiration Healthcare Group Plc

16.75
0.00 (0.00%)
08 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Inspiration Healthcare Group Plc IHC London Ordinary Share
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 16.75 08:00:00
Open Price Low Price High Price Close Price Previous Close
16.75 16.75 16.75 16.75 16.75
more quote information »
Industry Sector
HEALTH CARE EQUIPMENT & SERVICES

Inspiration Healthcare IHC Dividends History

Announcement Date Type Currency Dividend Amount Ex Date Record Date Payment Date
03/10/2023InterimGBP0.0020523/11/202324/11/202322/12/2023
03/05/2023FinalGBP0.004129/06/202330/06/202328/07/2023
04/10/2022InterimGBP0.0020524/11/202225/11/202228/12/2022
04/05/2022FinalGBP0.004130/06/202201/07/202229/07/2022
05/10/2021InterimGBP0.0020525/11/202126/11/202129/12/2021
27/04/2021FinalGBP0.00401/07/202102/07/202130/07/2021
06/10/2020InterimGBP0.00226/11/202027/11/202029/12/2020

Top Dividend Posts

Top Posts
Posted at 02/5/2024 09:42 by lammylover
From what I can see on twitter, its business as usual at IHC:


1/5/24
2 day training session in London, Home Care Team getting info on latest advances in healthcare tech.

30/4/24 Advertising for Senior Business Development Manager position.

29/4/24 Attending conference in B/ham


Hopefully the delayed contract is just a blip, and progress will be made this year..
Posted at 01/2/2024 15:32 by trmum
Thanks MTIOC, having stalked this board for a while now I can only offer the observation that when I found out there were nice new Porsches in the car park at IHC, I assumed the good times were about to role.

That now seems a bit tone deaf by Campbell et al. And my assumptions also terrible.

Old chair seemed happy with everything, as you say, hope new chair evaluates decision making over past few years, not excuses ("error-prone"), and takes some decisive action.
Posted at 31/1/2024 18:27 by hedgehog 100
Dogwalker,

We didn't know today that a covenant waiver would be necessary, so it's a bit of a stretch to call it good news.

I think that's why IHC is down 29.91% today (down 16p, from 53.5p to 37.5p).
Posted at 04/1/2024 17:50 by mtioc
Geovest, I agree. Really hard to sell in US without local knowledge and presence. Each state can have different regulations and distributors. Like you I wonder if it is too small.

This suggests that management have a reasonable confidence in FDA approval for ventilators. If approval received and IHC manages to achieve actual sales (both big ifs), it would shift valuation.
Posted at 16/10/2023 09:17 by redwing1
Blackhorse23 - why would anyone care what you have switched to? You lurch around from one failed investment idea to the next (CURY, IHC, APH etc) losing money each time and still have the audacity to keep spouting on this bulletin board as though you are some sort of investment guru.
Posted at 14/10/2023 14:48 by timbo003
Register for the seminar mentioned in the previous post (which includes a presentation from IHC) here:
Posted at 14/10/2023 11:42 by sharesoc
ShareSoc is holding its first hybrid event in London on 19th Oct. Hear from Inspiration Healthcare Group (IHC) and other healthcare companies like Tristel Plc (TSTL), Creo Medical Group (CREO), Abingdon Health (ABDX) and GENincode (GENI). Attend in-person or online.📍 7760; Register: [...]
Posted at 11/10/2023 11:18 by lammylover
gopher - I've emailed the IHC PR company about share price concerns and suggested BOD buy some shares etc to show some confidence in business..
Posted at 09/10/2023 12:41 by lammylover
Shares large and particularly small getting battered at present by global events and fears. PIs just putting money into bank accounts for their 5% guaranteed return.
Its making some AIM stocks look ridiculously undervalued and surely ripe for a takeover (and we are seeing plenty of private equity doing just that) IHC could do with Director buys to support the share price. Personally I'd be happy with a takeover here and someone who can deliver value from what should be easy to get big contract wins on what is non discretionary spending for hospitals etc.
Posted at 04/9/2023 10:55 by mtioc
Just catching up. I have owned this for a while.

This is a poor, early and big miss of a self-selected target. I have not seen Liberum note, but crudely appears to be a £3m revenue miss at a GM of 48%, so c. £1.5m profit hit, but seems to be £1.2m in broker's estimate.

IHC has just appointed new brokers and PR advisers to generate institutional interest that could include supporting acquisitions. The one thing they could not afford to do was “miss their numbers”.

I think there are some fundamental problems. Before the SLE acquisition, the group was a distributor of others’ products into the UK and Eire market. The acquisition added the complexity of manufacturing and worldwide distribution. It seems this has been too much for the management team: lack of controls led to a working capital cash suck (that is slowly unwinding under an interim and now a new CFO); they overspent (£1-2m?) on the new facility that has numerous vanity features, and their reporting/forecasting is awry. Initially, I thought the lack of transparency was due to confidentiality concerns, but increasingly I suspect they do not understand their profit and cash cycle by product line. I don't think they are ready to make further acquisitions until they have proved the previous ones and sorted the core.

There needs to be change. The chair has been involved since 2001 and since the float in 2015. A new, possibly exec chair, with Danagher/GE sector/ops experience should come in. That chair should have a wide remit to review the strategy and team competency. Four non-execs is probably at least one too many for a company this size and, given the finance issues, the finance related NED should also step down. That should allow the appointment to be cost neutral. I wonder how active the institutions led by BGF will be - it is very small.

I still think there is value in IHC’s position in neonatal distribution and equipment. On the equipment side, SLE’s automated oxygen control algorithms and equipment appear quite unique. The upside is US approval for its system. Even if that does not happen, the business should be cash generative and I suspect trade or PE would pay more than the year end EV (where I expect the working capital to swing the other way to turn net debt into a cash position).

I will hold for a while longer.

Your Recent History

Delayed Upgrade Clock